posttransl
modif
singl
unit
monoadpribosyl
polymer
chain
polyadpribosyl
adpribos
conjug
protein
adpribosyltransferas
posttransl
modif
adpribosyltransferas
also
known
parp
respons
synthesi
found
play
role
nearli
major
cellular
process
includ
dna
repair
transcript
translat
cell
signal
cell
death
furthermor
dysregul
adpribosyl
link
diseas
includ
cancer
diabet
neurodegen
disord
heart
failur
lead
develop
therapeut
parp
inhibitor
mani
current
clinic
trial
studi
therapeut
import
modif
recent
bolster
applic
mass
spectrometrybas
proteom
arguabl
power
tool
unbias
analysi
protein
modif
unfortun
progress
hamper
inher
challeng
stem
physicochem
properti
adpribos
posttransl
modif
highli
charg
heterogen
linear
branch
polym
well
monom
labil
found
wide
rang
amino
acid
acceptor
perspect
discuss
progress
made
address
challeng
includ
recent
breakthrough
proteom
techniqu
identifi
adpribosyl
site
futur
develop
provid
proteomewid
view
mani
cellular
process
regul
adpribosyl
molecular
cell
june
elsevi
inc
perspect
adpribosyl
refer
transfer
adpribos
group
nad
target
protein
posttransl
posttransl
modif
ptm
ad
onto
amino
acid
divers
chemistri
includ
aspart
glutam
lysin
arginin
cystein
adpribos
group
attach
singli
mono
adpribos
mar
polymer
chain
poli
adpribos
par
enzymat
activ
member
famili
human
adpribosyltransferas
art
commonli
known
poli
adpribos
polymeras
parp
vya
et
al
well
subset
nad
depend
sirtuin
houtkoop
et
al
togeth
mar
par
regul
fundament
cellular
process
role
signal
molecul
aredia
scovassi
perraud
et
al
posttransl
modif
feij
et
al
gibson
krau
addit
adpribosyl
shown
therapeut
import
modif
cancer
neurodegen
diseas
ischemia
inflammatori
disord
curtin
szabo
parp
hotli
pursu
drug
target
pharmaceut
compani
steffen
et
al
hundr
clinic
trial
treatment
cancer
carri
inhibitor
mani
ongo
trial
late
stage
garber
lord
et
al
notabl
anticanc
drug
also
crossreact
parp
wahlberg
et
al
increasingli
appreci
multifacet
role
cell
figur
tabl
gibson
krau
vya
et
al
identifi
substrat
specif
parp
help
elucid
distinct
function
famili
may
therapeut
implic
design
parp
inhibitorbas
therapi
recent
advanc
mass
spectrometri
ms
base
method
character
adpribosyl
protein
open
unpreced
possibl
explor
function
famili
enzym
provid
insight
clinic
relev
understudi
protein
modif
msbase
proteom
offer
three
type
data
genom
transcriptom
proteinprotein
interact
map
interactom
identif
protein
posttransl
modif
quantit
inform
protein
level
indepth
overview
potenti
held
msbase
proteom
recommend
cox
mann
complet
map
adpribosyl
proteom
includ
three
element
provid
insight
adpribosyl
substrat
regul
via
recruit
marparbind
protein
site
modif
abund
cell
adpribosyl
interactom
explor
last
decad
recent
msbase
techniqu
avail
identif
adpribosyl
site
proteom
scale
perspect
explor
msbase
proteom
help
address
sever
import
question
field
adpribosyl
signific
mani
potenti
amino
acid
attach
site
attach
regul
enzym
distinguish
site
mar
par
mani
possibl
structur
par
includ
length
branch
variant
import
distinct
increas
cellular
paryl
level
mean
reflect
increas
number
amino
acid
site
modif
increas
number
adpribos
unit
exist
site
increas
unconjug
par
level
adpribosyl
site
physiolog
signific
follow
section
discuss
inher
challeng
exist
solut
futur
need
address
critic
question
complet
function
understand
adpribosyl
proteom
investig
adpribosyl
proteom
mass
spectrometri
challeng
map
maryl
paryl
collect
adpribosyl
proteom
requir
robust
protocol
overcom
dynam
heterogen
labil
natur
modif
initi
challeng
variabl
par
attach
site
found
acid
basic
residu
list
expand
maryl
site
also
consid
see
later
section
variabl
result
wide
rang
chemic
enzymat
sensit
cervanteslaurean
et
al
greatli
hinder
identif
intact
complet
adpribosyl
proteom
second
modif
typic
found
low
level
cell
exhibit
fast
attachmentremov
kinet
wielcken
et
al
make
robust
enrich
method
critic
compon
elucid
adpribosyl
proteom
third
structur
par
polym
pose
practic
challeng
heterogen
subunit
vivo
branch
linear
highli
charg
characterist
incompat
ms
method
consid
method
address
overcom
subset
parp
link
nearli
major
cellular
process
juxtaposit
protein
identifi
eg
indic
involv
protein
regul
execut
cellular
process
enzymat
activ
indic
bubbl
color
blue
poli
adpribosyl
transferas
red
mono
adpribosyl
transferas
green
transferas
activ
refer
see
tabl
challeng
potenti
progress
remain
draft
adpribosyl
interactom
molecular
interact
serv
earli
indic
molecular
function
sizeabl
contribut
alreadi
made
field
adpribosyl
sever
largescal
proteom
studi
identifi
protein
associ
mar
andor
par
summar
figur
studi
use
common
experiment
design
human
cell
expos
dna
damag
agent
classic
stimul
paryl
activ
lyse
subject
enrich
adpribosyl
protein
follow
msbase
protein
identif
enrich
perform
rang
nondenatur
condit
studi
protein
identifi
includ
adpribosyl
protein
also
adpribos
bind
protein
larger
noncoval
interact
network
therebi
provid
aggreg
pictur
adpribosyl
interactom
use
protein
identifi
studi
tabl
draft
map
biolog
process
enrich
dna
damageinduc
adpribosyl
interactom
present
figur
figur
detail
dna
damag
respons
canon
role
paryl
cell
clear
addit
role
adpribosyl
present
even
follow
genom
insult
particular
signific
enrich
rna
process
factor
purpl
box
trend
note
individu
group
enrich
may
link
similar
chemic
electrostat
properti
par
rnacellular
biopolym
abl
share
bind
partner
eg
murawska
et
al
anoth
note
enrich
seen
cellular
macromolecular
complex
assembl
exemplifi
mitot
spindl
chang
et
al
nucleoli
boamah
et
al
stress
granul
leung
et
al
dna
repair
complex
okano
et
al
nuclear
matric
cardenascorona
et
al
possibl
owe
polymer
natur
par
plethora
par
bind
domain
may
target
polym
structur
scaffold
proteomewid
view
biolog
process
regul
adpribosyl
send
research
clinician
key
messag
reduct
adpribosyl
parp
inhibitor
impact
mani
aspect
cellular
function
seen
simpl
block
dna
repair
light
similar
experiment
design
method
chosen
cell
lysi
enrich
proven
critic
determin
interactom
observ
group
variat
enrich
method
adpribosyl
protein
produc
two
nearli
distinct
set
protein
see
figur
partli
result
bias
affin
antibodi
par
polym
longer
subunit
kawamitsu
et
al
macrodomain
enrich
maryl
paryl
protein
bias
affin
may
help
explain
macrodomainenrich
interactom
contain
known
adpribosyl
substrat
determin
inclus
site
identif
studi
antibodyenrich
interactom
see
figur
longer
polym
target
antibodi
may
serv
bait
par
bind
protein
interactor
interactom
separ
uniqu
network
base
lysi
buffer
composit
figur
support
mani
proteinprotein
proteinpar
interactor
noncoval
subject
charg
disrupt
note
nielsen
cowork
emphas
inclus
parp
inhibitor
cell
lysi
buffer
prevent
dna
shear
cell
lysi
procedur
activ
dna
damagerespons
parp
vitro
prevent
activ
cut
nonphysiolog
pardepend
interact
form
cell
lysat
figur
detail
version
treemap
gene
ontolog
determin
use
david
huang
et
al
treemap
construct
use
revigo
supek
et
al
r
r
develop
core
team
c
compil
protein
identifi
respons
dna
damag
broken
enrich
method
bait
cell
lysi
condit
comparison
lysi
condit
enrich
protein
analyz
euler
diagram
creat
vennmast
kestler
et
al
sourc
data
avail
tabl
identif
studi
shown
figur
pioneer
studi
highlight
import
consider
lysi
condit
enrich
method
clear
yet
approach
satur
probe
complet
adpribosyl
interactom
expect
complet
interactom
obtain
use
complementari
strategi
induc
enrich
adpribos
besid
dna
damag
equal
import
character
adpribosyl
interactom
cellular
stress
well
interactom
within
variou
parenrich
cellular
macromolecular
complex
healthi
unstress
cell
also
shown
maintain
low
basal
level
par
cellular
paryl
pattern
distinct
differ
stage
cell
cycl
differ
cellular
compart
vya
et
al
though
quit
common
increas
amount
endogen
adpribosyl
substrat
longterm
knockdown
par
degrad
enzym
parg
treatment
like
caus
nonphysiolog
chang
shown
parg
knockout
mous
min
et
al
recent
develop
cellperm
parg
inhibitor
may
provid
altern
increas
amount
substrat
without
requir
longterm
treatment
finch
et
al
prioriti
improv
exist
method
enrich
adpribosyl
substrat
review
vivelo
leung
increas
sensit
ms
detect
nativ
cell
condit
definit
adpribosyl
interactom
compos
coval
adpribosyl
substrat
adpribos
bind
protein
interact
protein
abil
synthes
mar
par
defin
number
adpribos
group
kistemak
et
al
lambrecht
et
al
tan
et
al
forese
refin
map
proteom
bind
singl
multipl
adpribos
group
noncoval
parallel
develop
techniqu
identifi
attach
site
adpribosyl
alreadi
allow
definit
identif
adpribosyl
substrat
proteom
level
see
next
section
combin
complementari
set
proteom
data
allow
research
precis
map
connect
within
adpribosyl
interactom
character
adpribosyl
level
amino
acid
attach
site
maryl
paryl
long
consid
two
class
ptm
use
perhap
accur
consid
attach
site
togeth
singl
modif
first
reason
consider
stem
knowledg
par
degrad
enzym
parg
slade
et
al
capabl
transform
paryl
substrat
maryl
one
effect
blur
line
site
mono
poli
adpribos
second
evid
cooper
effort
enzym
capabl
ad
mono
poli
adpribos
protein
mao
et
al
may
result
parp
ad
polym
exist
mar
initi
sitean
occurr
also
shown
vitro
elong
maryl
agaros
bead
panzet
et
al
notion
share
site
mar
par
synthesi
taken
demonstr
exhibit
maryl
activ
isol
paryl
activ
nativ
vault
protein
complex
chang
activ
presum
aris
cooper
member
complex
none
known
parp
kickhoef
et
al
vya
et
al
reason
character
adpribosyl
attach
site
remain
distinct
character
heterogen
molecul
monopoli
linearbranch
occupi
site
accordingli
msbase
method
adpribosyl
site
identif
discuss
section
restrict
identifi
site
ptm
attach
follow
remov
subunit
beyond
proteinproxim
monom
offer
inform
respect
origin
size
structur
correspond
ptm
major
analyt
challeng
identifi
adpribosyl
attach
site
come
wide
varieti
amino
acid
adpribosyl
includ
glutam
aspart
acid
serin
threonin
cervanteslaurean
et
al
phosphoserin
smith
stocken
cystein
mcdonald
asparagin
man
et
al
arginin
la
et
al
lysin
diphthamid
oppenheim
bodley
larg
collect
adpribos
acceptor
provid
number
uniqu
attach
structur
figur
enzymat
sensit
eg
acid
basic
amino
acid
lose
adpribos
presenc
high
ph
hydroxylamin
quickli
releas
adpribos
group
modifi
glutam
aspart
less
readili
arginin
adpribos
exclus
remov
arginin
presenc
adpribosyl
hydrolas
cervanteslaurean
et
al
moss
et
al
moss
et
al
though
major
adpribosyl
site
sensit
hydroxylamin
adamietz
hilz
hydroxylamineinsensit
site
lysin
may
also
serv
import
biolog
role
phosphoryl
tyrosin
site
rel
rare
comparison
phosphoserin
phosphothreonin
yet
play
indispens
role
cellular
biolog
olsen
et
al
would
import
therefor
studi
intracellular
protein
residueadpribos
attach
understand
signific
site
modif
sever
sampl
prepar
method
develop
studi
adpribosyl
site
ms
first
reli
unambigu
identif
maryl
site
identifi
dalton
mass
shift
unmodifi
form
peptid
figur
distinct
advantag
method
come
reliabl
fragment
modif
standard
peptid
fragment
provid
digest
poli
adpribos
simplifi
mono
adpribos
b
glycohydrolas
activ
c
phosphoribos
digest
phosphodiesteras
hydroxam
acid
deriv
though
exposur
hydroxylamin
note
hydroxylamin
treatment
adpribosyl
arginin
result
format
hydroxyam
adpribos
moss
et
al
therefor
like
leav
da
signatur
formerli
modifi
arginin
residu
glutamateaspart
residu
repres
acid
attach
site
red
use
illustr
diagnost
ion
confirm
adpribosyl
state
modifi
peptid
hengel
et
al
oetjen
et
al
tao
et
al
method
also
util
identif
paryl
site
follow
treatment
defin
substrat
vitro
parg
leav
mar
otherwis
mass
variant
par
attach
site
note
howev
inher
uncertainti
underli
subset
site
identif
follow
treatment
enzym
releas
free
adpribosea
molecul
shown
spontan
adpribosyl
n
terminu
protein
peptid
well
lysin
arginin
cystein
residu
vitro
kharadia
grave
modif
potenti
form
environ
rich
free
adpribos
eg
vicin
digest
occurr
signific
nonenzymat
modif
cell
remain
import
unansw
question
see
supplement
inform
discuss
presenc
current
attribut
exclus
either
sampl
prepar
intracellular
biolog
particularli
parg
enzym
capabl
produc
free
adpribos
present
scenario
field
would
greatli
benefit
perform
seri
experi
clearli
establish
dispel
whether
nonenzymat
adpribosyl
concern
proteom
studi
two
altern
demonstr
recent
studi
identifi
adpribosyl
site
proteom
level
first
methoddigest
mar
par
phosphoribos
attach
site
figur
chapman
et
al
hengel
goodlett
palazzo
et
al
reli
upon
pyrophosphatas
activ
either
snake
venom
phosphodiesteras
matsubara
et
al
standard
enzym
vitro
par
digest
human
recent
discov
adpribosyl
phosphodiesteras
less
effici
svp
synthes
recombin
protein
palazzo
et
al
similar
method
chemistri
attach
site
maintain
howev
isoadpribos
fragment
releas
phosphodiesteras
allow
format
reactiv
aldehyd
group
shown
respons
spontan
adpribosyl
appar
unbias
digest
par
mar
svp
suggest
method
amen
form
amino
acid
attach
inde
produc
acid
basic
nucleophil
site
identif
endogen
modifi
protein
vya
et
al
second
method
reli
upon
releas
adpribos
acid
glutam
aspart
amino
acid
residu
hydroxylamin
standard
method
distinguish
amino
acid
acceptor
adpribos
cervanteslaurean
et
al
util
method
lie
alter
acid
group
follow
hydroxylamin
releas
adpribos
figur
result
hydroxam
acid
deriv
produc
mass
shift
dalton
easili
distinguish
ms
figur
though
limit
identifi
acid
adpribosyl
site
method
provid
list
site
protein
acid
adpribosyl
proteom
highlight
first
time
widespread
modif
substrat
protein
cell
abil
definit
identifi
adpribosyl
site
possibl
begin
address
role
protein
adpribosyl
function
impact
modifi
site
extent
address
mutagenesi
studi
use
recombin
protein
target
genom
edit
techniqu
cell
howev
uniqu
difficulti
accompani
classic
mean
character
ptm
effect
point
mutat
limit
larg
number
amino
acid
adpribosyl
figur
exampl
mutat
glutam
acid
aspart
acid
guarante
lack
adpribosyl
requir
research
interest
block
adpribosyl
mutat
acid
site
nonacid
residu
requir
mutagenesi
strategi
complic
interpret
molecular
cellular
effectsi
adpribosyl
residu
import
loss
acid
residu
chang
structur
interact
network
protein
altern
block
adpribosyl
mutat
mean
chemic
strategi
develop
introduc
adpribos
group
specif
residu
purifi
peptid
kistemak
et
al
moyl
muir
van
der
heden
van
noort
et
al
techniqu
could
allow
research
mimic
adpribosyl
form
protein
conjug
modifi
peptid
interest
terminustermini
parent
protein
techniqu
term
semisynthesi
allow
function
analysi
phosphoryl
protein
vitro
szewczuk
et
al
anoth
way
ascertain
function
role
site
cell
involv
follow
modif
statu
tempor
upon
treatment
induc
inhibit
adpribosyl
exampl
quantit
proteom
techniqu
alreadi
util
map
tempor
coordin
adpribos
relat
protein
complex
respons
dna
damagea
necessari
step
toward
understand
mechan
adpribosedepend
dna
damag
repair
newli
develop
site
identif
techniqu
defin
tempor
chang
adpribosyl
substrat
site
level
potenti
indic
particular
site
physiolog
signific
addit
shown
subset
adpribosyl
site
within
proteom
sensit
treatment
chemotherapeut
parp
inhibitor
current
phase
iii
clinic
trial
variabl
respons
parp
inhibit
may
indic
mechan
action
drug
provid
molecular
basi
clinic
benefit
side
effect
observ
patient
given
larg
number
cellular
process
regul
parp
see
figur
interest
determin
share
uniqu
substrat
enzymat
activ
famili
member
use
protein
microarray
consist
protein
two
group
identifi
subproteom
modifi
vitro
feij
et
al
troiani
et
al
altern
cohen
group
engin
mutant
specif
use
bioorthogon
nad
analog
identif
respect
parpspecif
substrat
nuclear
extract
vitro
carteroconnel
et
al
major
protein
modifi
individu
parp
distinct
suggest
parp
exhibit
uniqu
substrat
specif
figur
tabl
coupl
site
identif
techniqu
possibl
determin
whether
defin
motif
surround
adpribosyl
site
modifi
parp
exampl
whether
parp
respons
consensu
sequenc
pxe
e
p
pxxe
e
xxg
surround
modifi
glutam
e
residu
identifi
yu
group
recent
similar
experiment
design
may
allow
us
deduc
whether
specif
motif
modif
individu
parp
identifi
substrat
guettler
et
al
one
puzzl
piec
data
current
studi
adpribosyl
site
automodifi
parp
found
divers
amino
acid
acid
gluasp
basic
ly
substrat
identifi
three
studi
use
protein
array
analogsensit
mutant
protein
identif
see
text
euler
diagram
creat
vennmast
sourc
data
avail
tabl
arg
nucleophil
cy
residu
appar
lack
specif
true
parp
add
multipl
singl
adpribos
group
vya
et
al
flexibl
aminoacid
acceptor
residu
argu
amino
acid
specif
enzym
least
vitro
automodif
one
possibl
explan
parp
act
nadas
hydrolyz
nad
vitro
releas
adpribos
group
nonenzymat
conjug
reactiv
amino
acid
residu
though
studi
yet
investig
nonenzymat
modif
parp
cervanteslaurean
et
al
show
histon
modifi
nonenzymat
incub
adpribos
vitro
deduc
lysin
primari
site
hand
cystein
residu
identifi
automodifi
vitro
suggest
certain
parp
may
defin
amino
acid
specif
vya
et
al
therefor
interest
examin
whether
amino
acid
prefer
endogen
protein
substrat
parp
proteomewid
scale
one
major
drawback
current
techniqu
identifi
proteomewid
enzymesubstr
relationship
experi
perform
vitro
thu
lose
proper
physiolog
context
eg
cellular
local
enzym
concentr
protein
modif
state
therefor
techniqu
urgent
need
identifi
parpspecif
proteom
cell
far
hydrolas
remov
singl
adpribos
group
arginin
glutam
identifi
tabl
clear
whether
modif
amino
acid
revers
hydrolas
exhibit
amino
acid
specif
regard
adpribos
remov
similarli
would
biolog
tabl
current
understand
wellstudi
adpribos
bind
domain
hydrolas
green
ye
red
er
hydrolysi
shown
specif
glutam
arginin
residu
respect
md
macrodomain
na
applic
blank
possibl
current
unknown
sarscov
sever
acut
respiratori
syndromecoronaviru
hev
hepat
e
viru
sfv
semliki
forest
viru
slade
et
al
l
remov
complet
par
chain
modifi
glutam
residu
rather
hydrolyz
glycosid
bond
subunit
par
parg
rosenth
et
al
sharifi
et
al
konczalik
moss
ohno
et
al
oka
et
al
n
modul
bind
adpribos
group
macrodomain
substrat
amino
acid
bind
specif
notabl
specif
macrodomain
shown
depend
amino
acid
surround
modifi
site
moyl
muir
thu
macrodomain
like
enrich
restrict
set
endogen
adpribosyl
protein
recent
compar
adpribosyl
proteom
human
mous
cell
enrich
macrodomain
group
found
macrodomainenrich
proteom
select
adpribosyl
glutam
residu
global
consist
earlier
find
macrodomain
bear
hydrolas
activ
acid
maryl
amino
acid
singl
substrat
rosenth
et
al
postul
glutam
site
identifi
follow
enrich
macrodomain
paryl
prior
enrich
mar
would
hydrolyz
use
line
reason
bind
hydrolas
specif
target
adpribosyl
residu
neighbor
amino
acid
adpribos
bind
modul
systemat
defin
tabl
summar
bind
affin
substrat
specif
moststudi
adpribos
bind
domain
hydrolas
primari
aim
character
studi
often
elucid
role
protein
domain
play
cell
biolog
also
provid
muchneed
expans
biolog
toolbox
distinguish
class
adpribosyl
substrat
effort
began
year
ago
classif
substrat
carri
maryl
arginin
residu
ohno
et
al
toolbox
provid
mean
enrich
target
group
adpribosyl
protein
expand
knowledg
adpribosyl
proteom
advisableand
point
possibleto
studi
attach
site
form
adpribosyl
togeth
distinct
mar
par
well
mani
subclass
par
like
prove
critic
interpret
role
play
modifi
residu
interest
exampl
five
enzymat
activ
human
parp
respons
paryl
activ
restrict
maryl
figur
mean
chang
paryl
statu
residu
attribut
enzymat
activ
five
parp
similar
analysi
could
employ
adpribosyl
hydrolas
two
remov
mar
two
turn
par
mar
parg
one
remov
par
mar
see
tabl
barkauskait
et
al
therefor
understand
adpribosyl
site
chang
unmodifi
state
carri
mar
par
suggest
enzym
respons
regul
clinic
implic
understand
distinct
par
versu
mar
exemplifi
parp
inhibitor
classif
perform
wahlberg
et
al
parp
inhibitor
assay
abil
bind
member
human
parp
famili
mani
inhibitor
bind
maryl
well
paryl
member
famili
wahlberg
et
al
potenti
offtarget
inhibit
maryl
would
reveal
typic
assay
monitor
effect
parp
inhibitor
measur
chang
paryl
level
know
adpribosyl
site
affect
inhibitor
diseas
state
adpribosyl
site
chang
unmodifi
maryl
paryl
predict
parp
target
cell
final
multipl
adpribos
group
par
may
defin
function
role
distinct
mar
exampl
wildtyp
parylationcap
abl
fulli
rescu
dna
repair
mef
mutant
capabl
maryl
activ
mortusewicz
et
al
detriment
chang
brought
convert
paryl
maryl
site
may
structur
par
similar
polynucl
acid
eg
dna
thu
could
compet
modul
function
factor
bind
nucleic
acid
reason
examin
potenti
method
classifi
site
adpribosyl
base
structur
ptm
diagram
figur
mar
homogen
modif
predict
mass
dalton
allow
maryl
site
local
ms
given
maryl
peptid
captur
phosphopeptid
enrich
techniqu
la
et
al
feasibl
global
enrich
maryl
peptid
proteasedigest
cell
lysat
fact
reanalysi
phosphoproteom
data
uncov
maryl
protein
matic
et
al
howev
reanalysi
like
underestim
global
level
maryl
due
high
ph
ph
phosphopeptid
elut
employ
huttlin
et
al
condit
result
loss
adpribos
group
conjug
acid
site
cervanteslaurean
et
al
consist
one
maryl
site
identifi
reanalysi
arginin
observ
otherwis
attribut
increas
stabil
adpribosyl
arginin
oppos
adpribosyl
glutam
condit
employ
studi
matic
et
al
nonbias
detect
maryl
proteom
labil
bond
adpribos
group
acid
amino
acid
must
preserv
eg
choos
neutral
phosphat
buffer
elut
phosphopeptid
enrich
matric
anoth
possibl
distinguish
maryl
substrat
paryl
substrat
exploit
distinct
properti
protein
domain
specif
recogn
see
biolog
toolbox
tabl
exampl
wwe
domain
recogn
isoadpriboseth
molecular
structur
span
consecut
adp
ribos
subunit
par
wang
et
al
therefor
domain
could
ideal
tool
enrich
paryl
maryl
target
altern
engin
abrog
inher
adpribos
hydrolas
activ
retain
bind
specif
toward
maryl
substrat
howev
domain
test
singl
maryl
paryl
substrat
use
biolog
toolbox
proteomewid
investig
warrant
systemat
analys
adpribos
bind
modul
fulli
character
substrat
specif
bind
hydrolysi
freeconjug
branchedlinear
mani
form
poli
adpribos
besid
identifi
adpribosyl
site
ms
also
use
accur
quantit
par
level
femtomol
sensit
martello
et
al
assum
averag
chain
length
adpribos
unit
per
par
molecul
rkle
group
estim
par
moleculescel
nativ
cellular
condit
induc
moleculescel
upon
dna
damag
branch
frequenc
martello
et
al
combin
methodolog
site
identif
could
allow
research
deduc
whether
increas
paryl
result
new
paryl
site
andor
substrat
simpli
elong
exist
site
exist
substrat
howev
one
awar
altern
sourc
parth
solubl
par
attach
target
protein
exist
solubl
par
vivo
infer
mount
evid
parg
endoand
exoglycosid
activ
allow
enzym
produc
regul
level
free
par
barkauskait
et
al
addit
adpribosyl
hydrolas
shown
reduc
paryl
level
automodifi
without
releas
free
adpribos
vitro
sharifi
et
al
indic
entir
par
chain
could
releas
singl
unit
cell
cellular
implic
free
par
demonstr
releas
apoptosisinduc
factor
aif
follow
exposur
cell
free
par
effect
observ
presenc
digest
par
yu
et
al
final
adpribosyl
hydrolas
degrad
par
regul
releas
aif
cell
hypothet
abil
degrad
free
par
mashimo
et
al
notabl
cellular
par
level
import
clinic
paramet
measur
effect
parp
inhibitor
andor
chemotherapeut
agent
clinic
trial
nci
standard
oper
procedur
well
predict
biomark
propos
parp
inhibitor
sensit
gottipati
et
al
oplustilova
et
al
understand
conjug
state
cellular
par
necessari
accur
interpret
chang
paryl
level
current
approach
account
anoth
import
parameterth
structur
subclass
par
subclass
includ
length
variant
vya
et
al
well
branch
variant
parp
make
branch
polym
make
linear
polym
alvarezgonzalez
jacobson
et
al
rippmann
et
al
differ
could
function
impact
par
role
scaffold
differ
length
polym
alreadi
shown
recruit
distinct
popul
protein
eg
fahrer
et
al
potenti
mechan
tempor
coordin
cellular
process
leung
realini
althau
develop
proteom
tool
determin
polym
length
structur
cell
could
shed
light
uniqu
role
play
mani
form
par
recent
develop
purif
scheme
larg
amount
par
standard
defin
length
kistemak
et
al
lambrecht
et
al
tan
et
al
could
potenti
pave
way
character
length
polym
paryl
substrat
ultim
goal
use
ms
simultan
identifi
site
adpribosyl
number
adpribos
group
attach
modifi
site
technic
challeng
bear
remark
similar
problem
sitespecif
microheterogen
observ
nlink
glycosyl
structur
sugar
polym
attach
modifi
site
could
differ
length
vari
degre
branch
recent
advanc
search
algorithm
abl
map
simultan
glycosyl
site
number
sugar
moieti
branch
point
sugar
polym
attach
modifi
site
singl
protein
chandler
et
al
though
adpribos
moieti
carri
neg
charg
gener
mass
sugar
moieti
perhap
feasibl
map
modifi
site
short
oligom
mer
attach
singl
paryl
protein
futur
assess
physiolog
relev
adpribosyl
site
site
occup
complet
character
singl
adpribosyl
site
includ
accur
identif
four
factor
amino
acid
conjug
site
enzym
respons
addit
remov
modif
structur
makeup
modif
mono
poli
branch
site
occup
stoichiometri
progress
made
first
three
endeavor
discuss
last
aim
aid
determin
function
physiolog
relev
site
adpribosyl
function
therefor
regul
site
like
exhibit
defin
stoichiometr
chang
respons
stimulu
nonfunct
site
show
chang
chang
associ
consist
biolog
stimulu
appli
quantifi
chang
site
occup
howev
much
challeng
quantifi
chang
protein
level
measur
may
track
chang
intens
singl
peptid
oppos
mani
peptid
singl
protein
wu
et
al
addit
mani
modif
may
exist
low
stoichiometri
make
quantif
extra
sensit
variabl
introduc
sampl
prepar
challeng
mitig
use
intern
stableisotopelabel
standard
kettenbach
et
al
olsen
et
al
investig
site
occup
identif
robust
reproduc
chang
determin
site
potenti
test
two
hypothes
proteinpeptid
ntermin
lysin
arginin
cystein
modif
may
nonfunct
therefor
repres
biolog
nois
potenti
form
nonenzymat
adpribos
group
releas
par
degrad
andor
nadas
activ
parp
kharadia
grave
adpribosyl
protein
alway
residuespecif
may
occasion
map
protein
region
oppos
amino
acid
latter
hypothesi
propos
explain
paryl
wherein
region
identifi
paryl
acceptor
oppos
site
hu
et
al
observ
stand
contrast
paryl
tumor
suppressor
mutat
analysi
yield
three
paryl
site
account
nearli
paryl
present
substrat
kanai
et
al
mutat
three
residu
alanin
result
cytoplasm
accumul
biochem
experi
indic
sitespecif
paryl
block
interact
nuclear
export
receptor
kanai
et
al
regionspecif
well
sitespecif
mechan
appear
play
follow
automodif
event
care
character
number
ms
studi
recent
year
result
larg
number
site
identif
see
figur
sourc
data
tabl
chapman
et
al
et
al
sharifi
et
al
tao
et
al
sever
defin
modif
site
identifi
studi
also
regionssuch
c
terminu
wgr
domain
stretch
show
region
necessarili
sitespecif
overlap
studi
abil
monitor
whether
site
protein
region
exhibit
regulatori
pattern
associ
cellular
chang
provid
essenti
data
determin
rel
import
topdown
proteom
necessari
step
forward
come
link
adpribosyl
establish
network
integr
ptm
woodsmith
et
al
work
alreadi
done
link
paryl
ubiquitin
kang
et
al
zhang
et
al
well
adpribosyl
acetyl
kowieski
et
al
elucid
import
cellular
mechan
futur
find
brought
constant
develop
ms
analysi
softwar
critic
compon
ptm
identif
well
increas
avail
liquid
chromatographi
method
mass
analyz
compat
topdown
proteom
topdown
proteom
analyz
intact
protein
rather
peptid
result
proteolysi
method
often
distinguish
protein
proteoform
ie
gene
product
posttransl
process
multipl
way
often
function
implic
smith
et
al
tran
et
al
techniqu
proven
power
analysi
complex
proteoform
histon
variant
enabl
simultan
character
proteoform
boyn
et
al
recent
wholeprotein
kinet
acetyl
turnov
histon
zheng
et
al
way
topdown
proteom
could
facilit
identif
group
tempor
spatial
correl
adpribosyl
site
well
protein
modif
integr
adpribosyl
grow
network
ptm
potenti
reveal
novel
regulatori
role
adpribosyl
provid
context
physiolog
chang
brought
modul
power
monitor
interpret
proteomewid
chang
adpribosyl
state
promis
advanc
fundament
understand
adpribosyl
biolog
facilit
connect
cellular
patient
respons
therapeut
parp
inhibit
box
depth
proteom
clearli
advanc
invent
better
tool
enrich
adpribosyl
proteomesmarparbind
proteom
marparyl
proteom
parpspecif
proteom
cell
differ
cellular
condit
particularli
nativ
condit
understudi
due
low
level
adpribosyl
howev
procur
vast
amount
data
must
coupl
urgenc
address
basic
question
whether
site
ptm
attach
matter
whether
ptm
alway
ad
enzymat
function
consequ
ad
figur
automodif
site
schemat
includ
protein
domain
secondari
structur
helic
shown
red
b
sheet
yellow
automodif
site
identifi
least
two
independ
studi
shown
size
annot
residu
base
number
studi
identifi
modif
site
locat
c
terminu
brct
domain
identifi
ms
studi
shown
two
major
automodif
site
sourc
data
avail
tabl
identifi
site
adpribosyl
know
amino
acid
attach
inform
research
potenti
impact
modif
exampl
whether
ptm
switch
charg
state
modifi
amino
acid
class
enzym
like
respons
attach
remov
inform
allow
studi
mutat
amino
acid
attach
site
know
stoichiometri
modif
respond
stimuli
provid
clue
site
protein
region
import
regulatori
switch
distinguish
mar
mani
structur
par
singl
adpribosyl
site
may
repres
number
ptm
includ
mar
linear
par
branch
par
polym
rang
subunit
vivo
know
structur
paryl
question
allow
research
specul
consequ
result
buildup
neg
charg
potenti
ptm
serv
scaffold
recruit
parbind
partner
profil
cellular
respons
parp
inhibitor
proteomewid
view
adpribosyl
state
cell
tissu
may
reveal
molecular
basi
chemotherapeut
respons
inform
design
develop
parp
inhibitor
effect
therapi
investig
therapeut
import
yet
enigmat
protein
modif
detail
mechanist
level
supplement
inform
includ
two
figur
four
tabl
found
articl
onlin
http
support
exampl
literatur
connect
made
parp
cellular
process
figur
sourc
data
use
gener
adpribosyl
interactom
shown
figur
see
supplementari
text
criteria
data
inclus
tabl
parp
specif
substrat
sourc
data
use
gener
euler
diagram
show
specif
substrat
figur
tabl
automodif
site
identifi
sourc
data
use
gener
automodif
site
map
figur
